Get the Stockscreener App
89.32
3.00%
-2.76
After Hours:
89.00
-0.32
-0.36%
Genedx Holdings Corp stock is traded at $89.32, with a volume of 619.14K.
It is down -3.00% in the last 24 hours and up +14.51% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$92.08
Open:
$91.81
24h Volume:
619.14K
Relative Volume:
0.66
Market Cap:
$2.51B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-28.72
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-8.17%
1M Performance:
+14.51%
6M Performance:
+135.86%
1Y Performance:
+734.77%
1-Day Range:
$86.22
$92.72
1-Week Range:
$86.22
$98.83
52-Week Range:
$7.72
$115.60
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
89.32 | 2.51B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
508.90 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.09 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
117.33 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
406.29 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
181.43 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Revolutionary AI Tool by GeneDx Transforms Genetic Testing with 750,000 Clinical Sequences - StockTitan
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
GeneDx CEO Katherine Stueland sells $258,695 in company stock By Investing.com - Investing.com South Africa
Genedx CFO Kevin Feeley sells shares worth $87k - Investing.com
GeneDx CEO Katherine Stueland sells $258,695 in company stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Genedx CFO Kevin Feeley sells shares worth $87k By Investing.com - Investing.com UK
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? - Insider Monkey
10 Best Emerging Technology Stocks to Buy Now - Insider Monkey
Lisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics By Investing.com - Investing.com South Africa
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics - Investing.com India
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Principal Financial Group Inc. - Defense World
Rhumbline Advisers Buys 1,021 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Shares Surge Amid Strong Prospects - TipRanks
GeneDx Expanding Genetic Testing to Include Cerebral Palsy -March 04, 2025 at 09:53 am EST - Marketscreener.com
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short Interest - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Update - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings CorpWGS - PR Newswire
An Investigation Has Commenced on Behalf of GeneDx Holdings Corp. Shareholders. Contact Levi & Korsinsky to Discuss your WGS Losses. - ACCESS Newswire
GeneDx Holdings Corp. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWGS - ACCESS Newswire
New York State Common Retirement Fund Buys 52,843 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Why Investors Shouldn't Be Surprised By GeneDx Holdings Corp.'s (NASDAQ:WGS) 32% Share Price Surge - Simply Wall St
GeneDx Holdings Corp (NASDAQ: WGS) 0.89% Incline Turns Investors Away - Stocks Register
GeneDx Holdings Stock Soars on Strong Earnings - TipRanks
GeneDx Holdings Corp.: A Comprehensive Analysis - HPBL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect - Markets Insider
Head-To-Head Review: Vsee Health (NASDAQ:VSEE) versus GeneDx (NASDAQ:WGS) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
GeneDx (NASDAQ:WGS) Shares Down 6.3%Time to Sell? - MarketBeat
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
GeneDx Highlights Strong Growth in Earnings Call - TipRanks
GeneDx (NASDAQ:WGS) Announces Earnings Results, Beats Estimates By $0.66 EPS - MarketBeat
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Learn to Evaluate (WGS) using the Charts - Stock Traders Daily
The Goldman Sachs Group Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - Defense World
GeneDx (NASDAQ:WGS) Hits New 52-Week High on Better-Than-Expected Earnings - Armenian Reporter
Allspring Global Investments Holdings LLC Has $7.18 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp. SEC 10-K Report - TradingView
A Closer Look at GeneDx Hldgs's Options Market Dynamics - Benzinga
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - Markets Insider
Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' - Seeking Alpha
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - Insider Monkey
GeneDx price target raised to $135 from $118 at TD Cowen - TipRanks
3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2% - Simply Wall St
GeneDx Holdings Corp (WGS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
GeneDx (NASDAQ:WGS) Hits New 52-Week High After Better-Than-Expected Earnings - Defense World
GeneDx Reports Strong 2024 Growth and 2025 Outlook - TipRanks
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):